Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin G Phillips

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Urology|August 8, 2025
Clinical utility of urinary comprehensive genomic profiling in diagnosing metachronous upper tract urothelial carcinoma: a case reportPaul M Yonover, Ceressa T Ward, Brian C Mazzarella, et al.
Plos One|September 11, 2013
p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophilsAsako Itakura, Joseph E Aslan, Branden T Kusanto, et al.
American Journal of Physiology. Cell Physiology|November 21, 2014
The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulationKevin G Phillips, Angela M Lee, Garth W Tormoen, et al.
Cellular and Molecular Bioengineering|September 30, 2015
Effect of ionizing radiation on the physical biology of head and neck squamous cell carcinoma cellsSandra M Baker-Groberg, Sophia Bornstein, Jevgenia Zilberman-Rudenko, et al.
European Urology Oncology|October 15, 2024
Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer Treated with Nadofaragene FiradenovecVikram M Narayan, Come Tholomier, Sharada Mokkapati, et al.
The Journal of Urology|May 20, 2026
Urine tumor DNA testing identifies recurrence and monitors therapy response in patients with high-risk non-muscle-invasive bladder cancer receiving intravesical bacillus Calmette-GuérinHenning Bahlburg, Moritz Maas, Alberto Contreras-Sanz, et al.
Journal of Clinical Medicine|October 14, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of InterventionVincent T Bicocca, Kevin G Phillips, Daniel S Fischer, et al.
Molecular Oncology|September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapyGoran Rac, Hiten D Patel, Christopher James, et al.
American Journal of Physiology. Cell Physiology|March 10, 2021
Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and functionTony J Zheng, Elizabeth R Lofurno, Alexander R Melrose, et al.
Cellular and Molecular Bioengineering|February 25, 2014
Measurement science in the circulatory systemCasey M Jones, Sandra M Baker-Groberg, Flor A Cianchetti, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Urology|August 8, 2025
Clinical utility of urinary comprehensive genomic profiling in diagnosing metachronous upper tract urothelial carcinoma: a case reportPaul M Yonover, Ceressa T Ward, Brian C Mazzarella, et al.
Plos One|September 11, 2013
p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophilsAsako Itakura, Joseph E Aslan, Branden T Kusanto, et al.
American Journal of Physiology. Cell Physiology|November 21, 2014
The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulationKevin G Phillips, Angela M Lee, Garth W Tormoen, et al.
Cellular and Molecular Bioengineering|September 30, 2015
Effect of ionizing radiation on the physical biology of head and neck squamous cell carcinoma cellsSandra M Baker-Groberg, Sophia Bornstein, Jevgenia Zilberman-Rudenko, et al.
European Urology Oncology|October 15, 2024
Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer Treated with Nadofaragene FiradenovecVikram M Narayan, Come Tholomier, Sharada Mokkapati, et al.
The Journal of Urology|May 20, 2026
Urine tumor DNA testing identifies recurrence and monitors therapy response in patients with high-risk non-muscle-invasive bladder cancer receiving intravesical bacillus Calmette-GuérinHenning Bahlburg, Moritz Maas, Alberto Contreras-Sanz, et al.
Journal of Clinical Medicine|October 14, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of InterventionVincent T Bicocca, Kevin G Phillips, Daniel S Fischer, et al.
Molecular Oncology|September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapyGoran Rac, Hiten D Patel, Christopher James, et al.
American Journal of Physiology. Cell Physiology|March 10, 2021
Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and functionTony J Zheng, Elizabeth R Lofurno, Alexander R Melrose, et al.
Cellular and Molecular Bioengineering|February 25, 2014
Measurement science in the circulatory systemCasey M Jones, Sandra M Baker-Groberg, Flor A Cianchetti, et al.
Pageof 4